Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-71 |
filingDate |
1994-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819cf4966e158678bdf591c5da7d0959 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b47a6c0d1eacc46fe9ad49ba024fd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5d197bd8d2ba1bcd94b1395bac4bb96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521bb7541299db99ef0059932d0cf12a |
publicationDate |
1998-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5728565-A |
titleOfInvention |
Methods of preparing tissue plasminogen activator derivatives |
abstract |
Tissue plasminogen activator (t-PA) derivatives are produced in useful quantities using recombinant DNA techniques. Specific derivatives include amino acid deletion derivatives and amino acid substitution derivatives. A deletion derivative lacking the N-terminal first 68 amino acids is specifically exemplified having requisite t-PA characteristics. The invention disclosed thus enables the production of t-PA derivatives via recombinant means. Methods, expression vehicles and various host cells useful in the production of said t-PA derivatives are also disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008069857-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009297573-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006104969-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969295-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495322-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003096288-A1 |
priorityDate |
1982-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |